News

The dearth of medical expertise, treatment facilities and requisite diagnostic equipment to accurately diagnose lung cancer at the early stages, and effectively manage is fueling death among people ...
The inaugural "Fairways For Fresh Air" golf outing is set to tee off April 21, 2025, at The Heights Golf Club in Rancho ...
Imdelltra is associated with improvement in overall survival compared to local standard-of-care chemotherapy among patients with small cell lung cancer.
Special to Wesson NewsIn celebration of a decade of powerful advocacy and progress, Wesson resident and lung cancer advocate ...
Nearly a year after winning an accelerated approval for its DLL3-targeting small cell lung cancer (SCLC) therapy Imdelltra, ...
Therapies that unleash the immune system to fight tumors have greatly extended the lives of people with many types of cancer.
From new KRAS and HER2 inhibitors to home-administered immunotherapy, recent trials mark a turning point in how metastatic lung cancer is managed.
Baptist Health-Fort Smith introduces the ion robot to enhance early lung cancer detection in the River Valley.
The FDA is evaluating a new drug application for taletrectinib in patients with ROS1 fusion–positive non–small cell lung ...
Plasma-based molecular residual disease analysis shows the potential to predict disease recurrence in lung cancer patients by 4.7 months.
A new study in England shows a strong link between higher rates of chest x-ray referrals in general practice patients with symptoms, such as persistent cough, and earlier lung cancer diagnoses, along ...